The 37 references in paper N. Knyazheskaya P., Н. Княжеская П. (2014) “Глюкокортикостероиды при бронхиальной астме: от системного введения до небулайзерной терапии // Corticosteroids in bronchial asthma: from systemic exposure to nebulized therapy” / spz:neicon:pulmonology:y:2012:i:5:p:92-98

1
Barnes P.J., Pedersen S., Busse W.W.Efficacy and safety of inhaled corticosteroids. New Developments. Am. J. Respir. Care Med. 1998; 157 (suppl.): S51–S53.
(check this in PDF content)
2
Barnes P.J.Efficacy of inhaled corticosteroids in asthma. J. Allergy Clin. Immunol. 1998; 102 (4, pt 1): 531–538.
(check this in PDF content)
3
Цой А.Н. Параметры фармакокинетики современных ингаляционных глюкокортикостероидов. Пульмоно\n логия 1999; 2: 73–79.
(check this in PDF content)
4
Brokbank W., Brebner H., Pengelly C.D.R. Chronic asthma treated with aerosol hydrocortisone. Lancet 1956; 2: 807.
(check this in PDF content)
5
Adcock I.M.Molecular mechanisms of glucocorticosteroids action. Pulm. Pharm. Ther. 2000; 13: 115–126.
(check this in PDF content)
6
Rahman I., Mac Nee W. Role of transcription factors in inflammatory lung diseases. Thorax 1998; 53: 601–612.
(check this in PDF content)
7
Newton R.Molecular mechanisms of glucocorticoid action: what is important? Thorax 2000; 55: 603–613.
(check this in PDF content)
8
Brattstrand R. What factors determine anti\ninflammatory activity and selectivity of inhaled steroids. Eur. Respir. Rev. 1997; 7: 356–361.
(check this in PDF content)
9
Cox G., Ohtoshi T., Vancheri C. et al.Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am. J. Respir. Cell. Mol. Biol. 1991; 4: 525–531.
(check this in PDF content)
10
Lipworth B. Systemic adverse effects of inhaled corticos\n teroid therapy: A systematic review and meta\nanalysis. Arch. Intern. Med. 1999; 159: 941–945.
(check this in PDF content)
11
Skoner D.P., Maspero J., Banerji D. Assessment of the long\n term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics 2008; 121 (1): e1–e14.
(check this in PDF content)
12
WHO. Model list of Essential Medicine, 16thlist, March 2009. http://www.who.int/selection_medicines/committees/expert/ 17/ sixteenth_adult_list_en.pdf
(check this in PDF content)
13
Winkler J., Hochhaus G., Derendorf H.How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids. Proc. Am. Thorac. Soc. 2004; 1: 356–363.
(check this in PDF content)
14
Muers M.F. Overview of nebulizer treatment. Thorax 1997; 52 (Suppl. 2): S25–S30.
(check this in PDF content)
15
Muers M.F. The rational use of nebulizers in clinical prac\n tice. Eur. Respir. Rev. 1997; 7: 189–197.
(check this in PDF content)
16
British Thoracic Society Nebulizer Project Group. Nebulizer therapy. Guidelines. Thorax 1997; 52 (Suppl. 2): S4–S24.
(check this in PDF content)
17
Boe J., Dennis J.H., O`Driscoll B.R. European Respiratory Society Guidelines on the use of nebulizers. Eur. Respir. J. 2001; 18: 228–242.
(check this in PDF content)
18
Kendrick A.H., Smith E.C., Wilson R.S.E.Selecting and using nebuliser equipment. Thorax 1997; 52 (Suppl. 2): S92–S101.
(check this in PDF content)
19
Авдеев С.Н.Использование небулайзеров в клиничес\n кой практике. Рус. мед. журн. 2001; 9 (5): 189–196.
(check this in PDF content)
20
Авдеев С.Н. Устройства доставки ингаляционных пре\n паратов, используемые при терапии заболеваний дыха\n тельных путей. Рус. мед. журн. 2002; 10 (5): 255–261.
(check this in PDF content)
21
Nicolini G, Cremonesi G,Melani AS. Inhaled corticosteroid therapy with nebulized beclometasone dipropionate. Pulm. Pharmacol. Ther. 2010; 23 (3): 145–155.
(check this in PDF content)
22
Terzano C., Allegra L., Barkai L., Cremonesi G. Beclometha\n sone dipropionate versus budesonide inhalation suspension in children with mild to moderate persistent asthma. Eur. Rev. Med. Pharmacol. Sci. 2001; 5 (1): 17–24.
(check this in PDF content)
23
Terzano C., Ricci A., Burinschi V. et al.Comparison of the efficacy of beclomethasone dipropionate and fluticasone propionate suspensions for nebulization in adult patients with persistent asthma. Respir. Med. 2003; 97 (Suppl.): S35–S40.
(check this in PDF content)
24
Delacourt C., Dutau G., Lefrancois G. et al.Comparison of the efficacy and safety of nebulized beclometasone dipropi\n onate and budesonide in severe persistent childhood asth\n ma. Respir. Med. 2003; 97 (Suppl. B): S27–S33.
(check this in PDF content)
25
Волков И.К. Применение ингаляционного глюкокор\n тикостероида беклометазона дипропионата (Кленил УДВ) в базисной терапии бронхиальной астмы. Атмо\n сфера. Пульмонология и аллергология. 2012; 1: 30–33.
(check this in PDF content)
26
Food and Drug Administration. Sterility Requirement for Aqueous\nBased Drug Products for Oral Inhalation. Federal Register 2000; 65 (103): 34082–34089.
(check this in PDF content)
27
Nicholson K.G., Kent J., Ireland D.C.Respiratory viruses and exacerbations of asthma in adults. Br. Med. J. 1993; 307: 982–996. Княжеская Н.П.Глюкокортикостероиды при бронхиальной астме: от системного введения до небулайзерной терапии Княжеская Н.П.Глюкокортикостероиды при бронхиальной астме: от системного введения до небулайзерной терапии
(check this in PDF content)
28
McFadden E.R. Jr.Acute severe asthma. Am. J. Respir. Crit. Care Med. 2003; 168: 740–759.
(check this in PDF content)
29
Melani A.S. Nebulized corticosteroids in asthma and COPD. An Italian appraisal. Respir. Care 2012; 57 (7): 1161–1174.
(check this in PDF content)
30
Rodrigo G., Rodrigo C. Inhaled flunisolide for acute severe asthma. Am. J. Respir. Crit. Care Med. 1998; 157 (3, Pt 1): 698–703.
(check this in PDF content)
31
Higgenbottam T.W., Britton J., Lawrence D. et al. Compar\n ison of nebulised budesonide and prednisolone in severe asthma exacerbation in adults. Biodrugs 2000; 14: 247–254.
(check this in PDF content)
32
Овчаренко С.И., Передельская О.А., Морозова Н. В., Ма/ колкин В.И. Небулайзерная терапия бронхолитиками и суспензией пульмикорта в лечении тяжелого обост\n рения бронхиальной астмы. Пульмонология 2003; 6: 75–83.
(check this in PDF content)
33
Rodrigo G.J. Comparison of inhaled fluticasone with intra\n venous hydrocortisone in the treatment of adult acute asth\n ma. Am. J. Respir. Crit. Care Med. 2005; 171 (11): 1231–1236.
(check this in PDF content)
34
Авдеев С.Н., Жестков А.В., Лещенко И.K. и др. Небули\n зированный будесонид при тяжелом обострении брон\n хиальной астмы: сравнение с системными стероидами. Мультицентровое рандомизированное контролируе\n мое исследование. Пульмонология 2006; 4: 58–67.
(check this in PDF content)
35
Геппе Н.А., Петровский Ф. И. Пульмикорт суспензия при бронхиальной астме у детей – больше чем просто хорошее средство в ряду многих. Атмосфера. Пульмо\n нология и аллергология 2007; 1: 17–22.
(check this in PDF content)
36
Применение ингаляционных кортикостероидов при обострении бронхиальной астмы. Обзор рандомизиро\n ванных клинических испытаний: в клиниках и лабора\n ториях мира. Мед. вестник: российская врачебная газе\n та 2012; 5.
(check this in PDF content)
37
Bousquet J., Meziane H., Chanez P. et al. The response of two different dosages of beclometasone dipropionate sus\n pension for nebulization versus a standard dose of beclometasone dipropionate via a metered\ndose inhaler on bronchoprovocation testing in adults with asthma. Respir.
(check this in PDF content)